Navigation Links
Pro-Dex, Inc. Provides Updates on Key Developments
Date:4/16/2008

Company announces signing of new Development and Supply Agreement

Company expands Business Development capability

SANTA ANA, Calif., April 16 /PRNewswire-FirstCall/ -- PRO-DEX, INC. (Nasdaq: PDEX) announced today the completion of two key objectives that keeps the Company on a path to accelerated sales growth.

The Company announced that it has recently entered into a new Development and Supply Agreement with an existing customer in the orthopedic market. This is the same customer that the Company announced last year would be taking over the manufacture of its own product, a decision the customer subsequently reversed. Revenue from the development services to be provided by Pro-Dex are estimated at $250,000 over the next 12 months. Upon successful completion of the development services, Pro-Dex expects first-year sales of the newly developed device to be approximately $2.4 million. Launch of the new product is targeted for the next annual meeting of the American Academy of Orthopedic Surgeons in March of 2009.

Commenting on the Agreement, Pro-Dex's Executive Vice President, Patrick Johnson said, "We're pleased to announce the signing of our third major agreement this fiscal year. It is further confirmation that Pro-Dex's value proposition is attractive to the medical device market, and that we can effectively identify and capitalize on new opportunities. The signing of this Agreement is particularly satisfying as it marks a new beginning for a long-time customer relationship, a relationship that had become strained over the years but has been revitalized through powerful collaboration."

The Company also announced the re-hiring of James McKenney as its new Regional Director of Business Development. Mr. McKenney had previously worked for the Company in the position of Director of Sales and Marketing for its Santa Ana business group. "We are really excited about Jim re-joining Pro-Dex," commented Mr. Johnson. "He was a great contributor in the five years he previously worked for the Company and we are confident that he will make a significant contribution in this new role. Jim will be based in Florida where we already have several important medical device customers and where there are several other major potential new customers. Jim will focus on the accelerated growth of our medical device business, including the sales of motors designed and manufactured by our Carson City business unit."

Commenting on these developments, Mark Murphy, Pro-Dex's Chief Executive Officer said, "Over the last 18 months, we have invested in engineering, quality, and manufacturing to improve our ability to deliver on our value proposition. The signing of this third major agreement and the hiring of Jim McKenney are evidence of our intent to grow the top line. As we move into our new Irvine, California facility on April 28th, we will have a strong platform (both human and physical assets) from which to build the size and profitability of Pro-Dex."

Pro-Dex, Inc. specializes in Accelerating Possibilities in the development and manufacture of technology-based solutions that incorporate embedded motion control, miniature rotary drive systems and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets. Pro-Dex's products are found world-wide in hospitals, dental offices, medical engineering labs, scientific research facilities, commercial and military aircraft, and high tech manufacturing operations. For more information, visit the Company's website at http://www.pro-dex.com.

Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Pro-Dex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ECO2 Plastics, Inc. Reports 2007 Year End Financial Results, Announces FDA Filing and Provides Outlook for 2008
2. ApothecaryRx Provides Exit Strategy for Boomer Pharmacy Businesses; Sustains Service and Communication Structure of Community Pharmacies to Improve Drug Compliance, Reduce Drug Errors
3. Legal Aid Provides Access to Justice for Victims of Violent Crime
4. PreMD Provides Update on FDA Review
5. Publication Provides a Wake-Up Call For Clinicians Treating Narcolepsy
6. American Media, Inc. Provides Lenders With Updated Information
7. DURECT Provides Update on CHRONOGESIC(R) Research Program
8. LIFE Provides Medical Books and Surgical Supplies to Iraq
9. Comfort C(R) Provides Significantly Higher Absorption Than Other Leading Brand
10. Institute for Integrative Nutrition Provides Tips to Transition Bodies for Fall, Winter, Spring, Summer Eating
11. Flagship Global Health Provides 2008 Financial Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers of ... pain with a reputable physician in their area, announces the launch of a new ... for patients who are looking for reputable physicians to help them with back or ...
(Date:4/25/2017)... NJ (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed ... treatment of acute or chronic problems, I focus on preventative care with all my patients ... you have any questions, always feel free to contact my office and my trained staff ...
(Date:4/25/2017)... ... 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley ... in Writing, set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, ... Arizona College of Medicine. He also serves as Medical Director for the Bureau of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol ... is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex ... in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College ... nursing professionals advance their careers. Beginning in the fall of 2017, Emmanuel’s program will ... in as few as 16 months and for as little as $14,528. These changes ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... YORK , April 19, 2017 Global ... drainage devices are tubes used to remove excess liquid ... blood, serum, pus, urine, bile or lymph. Surgical drains ... of surgery such as orthopedics surgery, cardiovascular surgery, neurosurgery, ... is prophylactic post-surgery to prevent accumulation of fluid e.g. ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/18/2017)... 2017 Cogentix Medical, Inc. (NASDAQ: CGNT), a ... Uro/Gyn and Gynecology markets with innovative and proprietary products, ... March 31, 2017 after the market close on Tuesday, ... host a conference call and webcast to discuss its ... 2017 at 4:30 p.m. Eastern Time (3:30 p.m. Central ...
Breaking Medicine Technology: